BENZYL 3-METHYLENEAZETIDINE-1-CARBOXYLATE, 95.0%, 500mg

N-[2-Nitro-4-(trifluoromethyl)phenyl]pyrrolidine, 95+%, 5g

2,3-Dihydroxybenzoic Acid>98.0%(HPLC)(T)5g

4-Fluoro-4'-methoxybiphenyl, 96.0%, 250mg

N-(4-(4-(Trifluoromethoxy)phenyl)pyrimidin-2-yl)-1H-indazol-5-amine, 98+%, 10mg

4-(2-Keto-1-benzimidazolinyl)piperidine, 95.0%, 5g

2-Benzyl 8-(tert-butyl) 3-(hydroxymethyl)-2,8-diazaspiro[4.5]decane-2,8-dicarboxylate, 97%, 250mg

1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid, 98%, 1g

3-Bromoaniline, 99.0%, 500g

3-bromo-6-methyl-2H-indazol-5-amine, 95%, 1g

Éther diéthylique, min 99,5 %, pour la synthèse, stab., 25 l, blanc.

Methylmalonic acid diethyl ester, 97.0%, 100g

6-bromo-1H,2H,3H-pyrrolo[3,2-b]pyridine, 95.0%, 100mg